期刊文献+

大补元煎合蒙诺治疗慢性肾炎蛋白尿疗效观察 被引量:3

下载PDF
导出
摘要 目的:观察大补元煎加减联合蒙诺治疗原发性慢性肾炎蛋白尿脾肾气虚证的临床疗效。旨在为慢性肾炎脾肾气虚证的治疗提供一有效的方法。方法:收集符合标准的慢性肾炎患者60例,随机分为两组,治疗组采用大补元煎加减加蒙诺,予大补元煎为主加减,温服每日两次,加蒙诺10mg/天口服;对照组用蒙诺10mg/天口服治疗。疗程3个月,比较两组治疗前后症候积分、尿常规和24h尿蛋白定量。结果:疗程结束后,治疗组总积分下降明显[(7.10±1.05)→(4.43±2.16)],优于对照组[(6.86±2.18)→(5.88±2.03)],P<0.01;对照组在治疗后腰脊酸痛,疲倦乏力,浮肿,纳少脘胀等症候平均积分的比较,治疗组亦明显低于对照组(P<0.01);治疗组尿蛋白减少明显[(2.8±0.8)g/24h→(1.3±0.4)g/24h),经统计疗效优于对照组[(2.7±0.6)g/24h→(1.9±0.5)g/24h],P<0.05。结论:大补元煎加减联合蒙诺治疗慢性肾炎蛋白尿脾肾气虚证有较好的临床疗效。
出处 《辽宁中医杂志》 CAS 北大核心 2007年第8期1076-1077,共2页 Liaoning Journal of Traditional Chinese Medicine
基金 上海市重点学科建设项目资助(Y0302) 上海市"医苑新星"培养计划
  • 相关文献

参考文献4

二级参考文献16

  • 1Remuzzi G, Bertani T. The pathophysiology of progressive nephropathies. N Engl J Med, 1998,339:1448-1456.
  • 2William JD, Coles GA. Proteinuria-a direct cause of renal morbidity? Kidney Int. 1994,45:443-450.
  • 3Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med, 1993,329:1456-1462.
  • 4Morelli E, Loon N, Meyer T,et al.Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes, 1990,39:76- 82.
  • 5Lufft V, Kliem V, Hamkens A, et al. Antiproteinuric efficacy of fosinopril after renal transplantation is determined by the extent of vascular and tubulointerstitial damage. Clin Transplant, 1998, 12:409-415.
  • 6Rudberg S, Aperia A, Freyschuss U, et al. Enalapril reduces microalbuminuria in young normotensive type 1 (insulindependent) diabetic patients irrespective of its hypotensive effect. Diabetologia, 1990,33:470-476.
  • 7Ruggenenti P, Pema A, Gherardi G et al. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet, 1999,354:359-364.
  • 8Ruggenenti P, Pema A, Mosconi L, et al. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinurine, non-diabetic nephropathy . Lancet, 1997, 394:1857-1863.
  • 9Peters H, Border WA, Noble NA. Targeting TGF-β overexpression in renal disease: maximizing the antifibrotic action of angiotensin Ⅱ blockade. Kidney Int, 1998,54:1570-1580.
  • 10Packer M, Poole-Wilson A, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation, 1999,100:2312-2318.

共引文献103

同被引文献26

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部